nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—esophageal cancer	0.567	1	CbGaD
Etravirine—CYP2C9—Capecitabine—esophageal cancer	0.0751	0.433	CbGbCtD
Etravirine—CYP2C9—Cisplatin—esophageal cancer	0.0378	0.218	CbGbCtD
Etravirine—ABCB1—Cisplatin—esophageal cancer	0.0367	0.212	CbGbCtD
Etravirine—ABCB1—Methotrexate—esophageal cancer	0.0238	0.137	CbGbCtD
Etravirine—Rilpivirine—NR1I2—esophageal cancer	0.0105	0.858	CrCbGaD
Etravirine—Hepatic steatosis—Capecitabine—esophageal cancer	0.00355	0.0279	CcSEcCtD
Etravirine—Dyspnoea exertional—Capecitabine—esophageal cancer	0.00355	0.0279	CcSEcCtD
Etravirine—Drug hypersensitivity—Capecitabine—esophageal cancer	0.00266	0.021	CcSEcCtD
Etravirine—Prurigo—Capecitabine—esophageal cancer	0.00232	0.0183	CcSEcCtD
Etravirine—Swelling face—Capecitabine—esophageal cancer	0.00225	0.0177	CcSEcCtD
Etravirine—Osteonecrosis—Methotrexate—esophageal cancer	0.00214	0.0169	CcSEcCtD
Etravirine—Night sweats—Capecitabine—esophageal cancer	0.00199	0.0156	CcSEcCtD
Etravirine—Opportunistic infection—Methotrexate—esophageal cancer	0.00198	0.0156	CcSEcCtD
Etravirine—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00187	0.0147	CcSEcCtD
Etravirine—Infection—Carboplatin—esophageal cancer	0.00176	0.0138	CcSEcCtD
Etravirine—Rilpivirine—ABCB1—esophageal cancer	0.00174	0.141	CrCbGaD
Etravirine—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00164	0.0129	CcSEcCtD
Etravirine—Haemoglobin decreased—Capecitabine—esophageal cancer	0.00156	0.0123	CcSEcCtD
Etravirine—Haematemesis—Capecitabine—esophageal cancer	0.00154	0.0121	CcSEcCtD
Etravirine—Hepatomegaly—Capecitabine—esophageal cancer	0.00152	0.0119	CcSEcCtD
Etravirine—Pain—Carboplatin—esophageal cancer	0.00151	0.0119	CcSEcCtD
Etravirine—Blister—Capecitabine—esophageal cancer	0.00149	0.0117	CcSEcCtD
Etravirine—Body temperature increased—Carboplatin—esophageal cancer	0.0014	0.011	CcSEcCtD
Etravirine—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00119	0.00934	CcSEcCtD
Etravirine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00117	0.0092	CcSEcCtD
Etravirine—Haematemesis—Methotrexate—esophageal cancer	0.00115	0.00904	CcSEcCtD
Etravirine—Renal failure acute—Cisplatin—esophageal cancer	0.00114	0.009	CcSEcCtD
Etravirine—Amnesia—Cisplatin—esophageal cancer	0.00112	0.00884	CcSEcCtD
Etravirine—Inflammation—Capecitabine—esophageal cancer	0.00111	0.0087	CcSEcCtD
Etravirine—Breast disorder—Cisplatin—esophageal cancer	0.000955	0.00751	CcSEcCtD
Etravirine—Sleep disorder—Capecitabine—esophageal cancer	0.0009	0.00708	CcSEcCtD
Etravirine—Diabetes mellitus—Capecitabine—esophageal cancer	0.000896	0.00704	CcSEcCtD
Etravirine—Pancreatitis—Cisplatin—esophageal cancer	0.000896	0.00704	CcSEcCtD
Etravirine—Hepatic failure—Capecitabine—esophageal cancer	0.000867	0.00682	CcSEcCtD
Etravirine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000863	0.00679	CcSEcCtD
Etravirine—Renal failure acute—Capecitabine—esophageal cancer	0.000844	0.00663	CcSEcCtD
Etravirine—Amnesia—Capecitabine—esophageal cancer	0.000829	0.00652	CcSEcCtD
Etravirine—Inflammation—Methotrexate—esophageal cancer	0.000824	0.00648	CcSEcCtD
Etravirine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000822	0.00646	CcSEcCtD
Etravirine—Dermatitis bullous—Capecitabine—esophageal cancer	0.000815	0.00641	CcSEcCtD
Etravirine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000803	0.00631	CcSEcCtD
Etravirine—Renal failure—Cisplatin—esophageal cancer	0.000801	0.00629	CcSEcCtD
Etravirine—Myocardial infarction—Cisplatin—esophageal cancer	0.000798	0.00628	CcSEcCtD
Etravirine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000798	0.00628	CcSEcCtD
Etravirine—Stomatitis—Cisplatin—esophageal cancer	0.000794	0.00624	CcSEcCtD
Etravirine—Conjunctivitis—Cisplatin—esophageal cancer	0.000792	0.00622	CcSEcCtD
Etravirine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00077	0.00606	CcSEcCtD
Etravirine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000722	0.00568	CcSEcCtD
Etravirine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000719	0.00565	CcSEcCtD
Etravirine—Urethral disorder—Cisplatin—esophageal cancer	0.000717	0.00564	CcSEcCtD
Etravirine—Gynaecomastia—Methotrexate—esophageal cancer	0.000715	0.00562	CcSEcCtD
Etravirine—Dry skin—Capecitabine—esophageal cancer	0.000714	0.00561	CcSEcCtD
Etravirine—Breast disorder—Capecitabine—esophageal cancer	0.000704	0.00554	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000702	0.00552	CcSEcCtD
Etravirine—Gastritis—Capecitabine—esophageal cancer	0.00069	0.00542	CcSEcCtD
Etravirine—Eye disorder—Cisplatin—esophageal cancer	0.000683	0.00537	CcSEcCtD
Etravirine—Cardiac disorder—Cisplatin—esophageal cancer	0.000679	0.00534	CcSEcCtD
Etravirine—Abdominal distension—Capecitabine—esophageal cancer	0.000678	0.00533	CcSEcCtD
Etravirine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000667	0.00524	CcSEcCtD
Etravirine—Bronchospasm—Capecitabine—esophageal cancer	0.000662	0.00521	CcSEcCtD
Etravirine—Immune system disorder—Cisplatin—esophageal cancer	0.00066	0.00519	CcSEcCtD
Etravirine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000659	0.00518	CcSEcCtD
Etravirine—Angina pectoris—Capecitabine—esophageal cancer	0.000656	0.00516	CcSEcCtD
Etravirine—Hepatic failure—Methotrexate—esophageal cancer	0.000645	0.00507	CcSEcCtD
Etravirine—Malnutrition—Cisplatin—esophageal cancer	0.000637	0.005	CcSEcCtD
Etravirine—Renal failure acute—Methotrexate—esophageal cancer	0.000628	0.00494	CcSEcCtD
Etravirine—Flatulence—Cisplatin—esophageal cancer	0.000627	0.00493	CcSEcCtD
Etravirine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000607	0.00478	CcSEcCtD
Etravirine—Vision blurred—Cisplatin—esophageal cancer	0.0006	0.00472	CcSEcCtD
Etravirine—Tremor—Cisplatin—esophageal cancer	0.000596	0.00469	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000595	0.00468	CcSEcCtD
Etravirine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000592	0.00465	CcSEcCtD
Etravirine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000591	0.00464	CcSEcCtD
Etravirine—Renal failure—Capecitabine—esophageal cancer	0.00059	0.00464	CcSEcCtD
Etravirine—Myocardial infarction—Capecitabine—esophageal cancer	0.000589	0.00463	CcSEcCtD
Etravirine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000589	0.00463	CcSEcCtD
Etravirine—Anaemia—Cisplatin—esophageal cancer	0.000588	0.00463	CcSEcCtD
Etravirine—Stomatitis—Capecitabine—esophageal cancer	0.000585	0.0046	CcSEcCtD
Etravirine—Conjunctivitis—Capecitabine—esophageal cancer	0.000584	0.00459	CcSEcCtD
Etravirine—Malaise—Cisplatin—esophageal cancer	0.000574	0.00451	CcSEcCtD
Etravirine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000568	0.00446	CcSEcCtD
Etravirine—Convulsion—Cisplatin—esophageal cancer	0.000551	0.00434	CcSEcCtD
Etravirine—Anxiety—Cisplatin—esophageal cancer	0.00054	0.00425	CcSEcCtD
Etravirine—Hepatitis—Capecitabine—esophageal cancer	0.000539	0.00424	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000538	0.00423	CcSEcCtD
Etravirine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000536	0.00422	CcSEcCtD
Etravirine—Discomfort—Cisplatin—esophageal cancer	0.000535	0.00421	CcSEcCtD
Etravirine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000532	0.00418	CcSEcCtD
Etravirine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00053	0.00416	CcSEcCtD
Etravirine—Urethral disorder—Capecitabine—esophageal cancer	0.000528	0.00415	CcSEcCtD
Etravirine—Breast disorder—Methotrexate—esophageal cancer	0.000524	0.00412	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000522	0.00411	CcSEcCtD
Etravirine—Infection—Cisplatin—esophageal cancer	0.000516	0.00406	CcSEcCtD
Etravirine—Erythema multiforme—Capecitabine—esophageal cancer	0.00051	0.00401	CcSEcCtD
Etravirine—Nervous system disorder—Cisplatin—esophageal cancer	0.000509	0.00401	CcSEcCtD
Etravirine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000509	0.004	CcSEcCtD
Etravirine—Skin disorder—Cisplatin—esophageal cancer	0.000505	0.00397	CcSEcCtD
Etravirine—Eye disorder—Capecitabine—esophageal cancer	0.000504	0.00396	CcSEcCtD
Etravirine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000502	0.00395	CcSEcCtD
Etravirine—Cardiac disorder—Capecitabine—esophageal cancer	0.0005	0.00393	CcSEcCtD
Etravirine—Eosinophilia—Methotrexate—esophageal cancer	0.000496	0.0039	CcSEcCtD
Etravirine—Anorexia—Cisplatin—esophageal cancer	0.000495	0.00389	CcSEcCtD
Etravirine—Pancreatitis—Methotrexate—esophageal cancer	0.000491	0.00386	CcSEcCtD
Etravirine—Angiopathy—Capecitabine—esophageal cancer	0.000489	0.00384	CcSEcCtD
Etravirine—Immune system disorder—Capecitabine—esophageal cancer	0.000487	0.00383	CcSEcCtD
Etravirine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000486	0.00382	CcSEcCtD
Etravirine—Mental disorder—Capecitabine—esophageal cancer	0.000472	0.00371	CcSEcCtD
Etravirine—Malnutrition—Capecitabine—esophageal cancer	0.000469	0.00369	CcSEcCtD
Etravirine—Paraesthesia—Cisplatin—esophageal cancer	0.000466	0.00367	CcSEcCtD
Etravirine—Flatulence—Capecitabine—esophageal cancer	0.000462	0.00363	CcSEcCtD
Etravirine—Decreased appetite—Cisplatin—esophageal cancer	0.000452	0.00355	CcSEcCtD
Etravirine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000448	0.00353	CcSEcCtD
Etravirine—Pain—Cisplatin—esophageal cancer	0.000444	0.00349	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000443	0.00348	CcSEcCtD
Etravirine—Vision blurred—Capecitabine—esophageal cancer	0.000442	0.00348	CcSEcCtD
Etravirine—Tremor—Capecitabine—esophageal cancer	0.00044	0.00346	CcSEcCtD
Etravirine—Renal failure—Methotrexate—esophageal cancer	0.000439	0.00345	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—esophageal cancer	0.000436	0.00343	CcSEcCtD
Etravirine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000435	0.00342	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—esophageal cancer	0.000434	0.00342	CcSEcCtD
Etravirine—Anaemia—Capecitabine—esophageal cancer	0.000434	0.00341	CcSEcCtD
Etravirine—Feeling abnormal—Cisplatin—esophageal cancer	0.000428	0.00337	CcSEcCtD
Etravirine—Malaise—Capecitabine—esophageal cancer	0.000423	0.00333	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000423	0.00332	CcSEcCtD
Etravirine—Vertigo—Capecitabine—esophageal cancer	0.000422	0.00331	CcSEcCtD
Etravirine—Syncope—Capecitabine—esophageal cancer	0.000421	0.00331	CcSEcCtD
Etravirine—Loss of consciousness—Capecitabine—esophageal cancer	0.000412	0.00324	CcSEcCtD
Etravirine—Body temperature increased—Cisplatin—esophageal cancer	0.000411	0.00323	CcSEcCtD
Etravirine—Hypertension—Capecitabine—esophageal cancer	0.000405	0.00318	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—esophageal cancer	0.000401	0.00315	CcSEcCtD
Etravirine—Anxiety—Capecitabine—esophageal cancer	0.000398	0.00313	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000397	0.00312	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000396	0.00312	CcSEcCtD
Etravirine—Discomfort—Capecitabine—esophageal cancer	0.000395	0.0031	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—esophageal cancer	0.000393	0.00309	CcSEcCtD
Etravirine—Dry mouth—Capecitabine—esophageal cancer	0.000391	0.00307	CcSEcCtD
Etravirine—Confusional state—Capecitabine—esophageal cancer	0.000386	0.00304	CcSEcCtD
Etravirine—Hypersensitivity—Cisplatin—esophageal cancer	0.000383	0.00301	CcSEcCtD
Etravirine—Infection—Capecitabine—esophageal cancer	0.00038	0.00299	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—esophageal cancer	0.000379	0.00298	CcSEcCtD
Etravirine—Shock—Capecitabine—esophageal cancer	0.000377	0.00296	CcSEcCtD
Etravirine—Nervous system disorder—Capecitabine—esophageal cancer	0.000376	0.00295	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—esophageal cancer	0.000375	0.00295	CcSEcCtD
Etravirine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000375	0.00295	CcSEcCtD
Etravirine—Asthenia—Cisplatin—esophageal cancer	0.000373	0.00293	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—esophageal cancer	0.000372	0.00293	CcSEcCtD
Etravirine—Skin disorder—Capecitabine—esophageal cancer	0.000372	0.00292	CcSEcCtD
Etravirine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00037	0.00291	CcSEcCtD
Etravirine—Anorexia—Capecitabine—esophageal cancer	0.000365	0.00287	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—esophageal cancer	0.000364	0.00286	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—esophageal cancer	0.000362	0.00285	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000362	0.00284	CcSEcCtD
Etravirine—Diarrhoea—Cisplatin—esophageal cancer	0.000355	0.00279	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—esophageal cancer	0.000352	0.00276	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—esophageal cancer	0.000349	0.00275	CcSEcCtD
Etravirine—Insomnia—Capecitabine—esophageal cancer	0.000346	0.00272	CcSEcCtD
Etravirine—Paraesthesia—Capecitabine—esophageal cancer	0.000344	0.0027	CcSEcCtD
Etravirine—Decreased appetite—Capecitabine—esophageal cancer	0.000333	0.00262	CcSEcCtD
Etravirine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000331	0.0026	CcSEcCtD
Etravirine—Vomiting—Cisplatin—esophageal cancer	0.00033	0.0026	CcSEcCtD
Etravirine—Fatigue—Capecitabine—esophageal cancer	0.00033	0.0026	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—esophageal cancer	0.000329	0.00259	CcSEcCtD
Etravirine—Rash—Cisplatin—esophageal cancer	0.000328	0.00258	CcSEcCtD
Etravirine—Pain—Capecitabine—esophageal cancer	0.000327	0.00257	CcSEcCtD
Etravirine—Constipation—Capecitabine—esophageal cancer	0.000327	0.00257	CcSEcCtD
Etravirine—Dermatitis—Cisplatin—esophageal cancer	0.000327	0.00257	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000324	0.00255	CcSEcCtD
Etravirine—Anaemia—Methotrexate—esophageal cancer	0.000323	0.00254	CcSEcCtD
Etravirine—Feeling abnormal—Capecitabine—esophageal cancer	0.000316	0.00248	CcSEcCtD
Etravirine—Malaise—Methotrexate—esophageal cancer	0.000315	0.00248	CcSEcCtD
Etravirine—Vertigo—Methotrexate—esophageal cancer	0.000314	0.00247	CcSEcCtD
Etravirine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000313	0.00246	CcSEcCtD
Etravirine—Nausea—Cisplatin—esophageal cancer	0.000309	0.00243	CcSEcCtD
Etravirine—Abdominal pain—Capecitabine—esophageal cancer	0.000303	0.00238	CcSEcCtD
Etravirine—Body temperature increased—Capecitabine—esophageal cancer	0.000303	0.00238	CcSEcCtD
Etravirine—Convulsion—Methotrexate—esophageal cancer	0.000303	0.00238	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000295	0.00232	CcSEcCtD
Etravirine—Discomfort—Methotrexate—esophageal cancer	0.000294	0.00231	CcSEcCtD
Etravirine—Confusional state—Methotrexate—esophageal cancer	0.000287	0.00226	CcSEcCtD
Etravirine—Infection—Methotrexate—esophageal cancer	0.000283	0.00223	CcSEcCtD
Etravirine—Hypersensitivity—Capecitabine—esophageal cancer	0.000282	0.00222	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—esophageal cancer	0.00028	0.0022	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000279	0.00219	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—esophageal cancer	0.000277	0.00218	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000276	0.00217	CcSEcCtD
Etravirine—Asthenia—Capecitabine—esophageal cancer	0.000275	0.00216	CcSEcCtD
Etravirine—Anorexia—Methotrexate—esophageal cancer	0.000272	0.00214	CcSEcCtD
Etravirine—Diarrhoea—Capecitabine—esophageal cancer	0.000262	0.00206	CcSEcCtD
Etravirine—Insomnia—Methotrexate—esophageal cancer	0.000258	0.00203	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—esophageal cancer	0.000256	0.00201	CcSEcCtD
Etravirine—Somnolence—Methotrexate—esophageal cancer	0.000253	0.00199	CcSEcCtD
Etravirine—Dizziness—Capecitabine—esophageal cancer	0.000253	0.00199	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—esophageal cancer	0.000248	0.00195	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000246	0.00193	CcSEcCtD
Etravirine—Fatigue—Methotrexate—esophageal cancer	0.000246	0.00193	CcSEcCtD
Etravirine—Pain—Methotrexate—esophageal cancer	0.000244	0.00192	CcSEcCtD
Etravirine—Vomiting—Capecitabine—esophageal cancer	0.000243	0.00191	CcSEcCtD
Etravirine—Rash—Capecitabine—esophageal cancer	0.000241	0.0019	CcSEcCtD
Etravirine—Dermatitis—Capecitabine—esophageal cancer	0.000241	0.0019	CcSEcCtD
Etravirine—Headache—Capecitabine—esophageal cancer	0.00024	0.00189	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—esophageal cancer	0.000235	0.00185	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000233	0.00183	CcSEcCtD
Etravirine—Nausea—Capecitabine—esophageal cancer	0.000227	0.00179	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—esophageal cancer	0.000225	0.00177	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—esophageal cancer	0.000225	0.00177	CcSEcCtD
Etravirine—ABCB4—Metabolism—CYP2A6—esophageal cancer	0.000218	0.00181	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000217	0.0018	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTO1—esophageal cancer	0.000216	0.0018	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000215	0.00179	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000212	0.00176	CbGpPWpGaD
Etravirine—Hypersensitivity—Methotrexate—esophageal cancer	0.00021	0.00165	CcSEcCtD
Etravirine—ABCB4—Metabolism—PTGS1—esophageal cancer	0.000207	0.00172	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ENO1—esophageal cancer	0.000207	0.00172	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000206	0.00171	CbGpPWpGaD
Etravirine—Asthenia—Methotrexate—esophageal cancer	0.000205	0.00161	CcSEcCtD
Etravirine—ABCB4—Metabolism—PSME1—esophageal cancer	0.000204	0.00169	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PSME2—esophageal cancer	0.000204	0.00169	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000203	0.00168	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.0002	0.00166	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000197	0.00164	CbGpPWpGaD
Etravirine—Diarrhoea—Methotrexate—esophageal cancer	0.000195	0.00153	CcSEcCtD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000192	0.00159	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00019	0.00158	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000189	0.00157	CbGpPWpGaD
Etravirine—Dizziness—Methotrexate—esophageal cancer	0.000189	0.00148	CcSEcCtD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000187	0.00155	CbGpPWpGaD
Etravirine—Vomiting—Methotrexate—esophageal cancer	0.000181	0.00142	CcSEcCtD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000181	0.0015	CbGpPWpGaD
Etravirine—Rash—Methotrexate—esophageal cancer	0.00018	0.00141	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—esophageal cancer	0.00018	0.00141	CcSEcCtD
Etravirine—CYP2C19—Biological oxidations—ALDH2—esophageal cancer	0.000179	0.00148	CbGpPWpGaD
Etravirine—Headache—Methotrexate—esophageal cancer	0.000179	0.0014	CcSEcCtD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000178	0.00148	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000178	0.00148	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP1B1—esophageal cancer	0.000176	0.00146	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000176	0.00146	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000175	0.00145	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000174	0.00144	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	0.00017	0.00141	CbGpPWpGaD
Etravirine—Nausea—Methotrexate—esophageal cancer	0.000169	0.00133	CcSEcCtD
Etravirine—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	0.000168	0.0014	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP19A1—esophageal cancer	0.000165	0.00137	CbGpPWpGaD
Etravirine—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000164	0.00136	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000163	0.00135	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	0.000159	0.00132	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000157	0.0013	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000155	0.00129	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000153	0.00127	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000153	0.00127	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000153	0.00127	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—HMOX1—esophageal cancer	0.000151	0.00125	CbGpPWpGaD
Etravirine—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.00015	0.00124	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000148	0.00123	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000145	0.00121	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ABCB1—esophageal cancer	0.000145	0.0012	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000144	0.0012	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000142	0.00118	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00014	0.00116	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00014	0.00116	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.000136	0.00113	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.000136	0.00112	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000134	0.00111	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000132	0.00109	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000131	0.00108	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.00013	0.00108	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000128	0.00106	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000127	0.00106	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000126	0.00104	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000124	0.00103	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000122	0.00101	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000122	0.00101	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000121	0.00101	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000119	0.000989	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.000118	0.000979	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000116	0.000964	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000115	0.000951	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000114	0.000946	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.00011	0.000908	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000108	0.000897	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000108	0.000892	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	0.000107	0.000885	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000103	0.000858	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000103	0.000856	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000102	0.000849	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000101	0.000839	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.0001	0.000831	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	9.89e-05	0.000821	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	9.89e-05	0.000821	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CREBBP—esophageal cancer	9.68e-05	0.000803	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	9.59e-05	0.000795	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	9.48e-05	0.000786	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.83e-05	0.000733	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—NOS3—esophageal cancer	8.67e-05	0.000719	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	8.15e-05	0.000676	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.06e-05	0.000668	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	8.04e-05	0.000667	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS2—esophageal cancer	7.93e-05	0.000657	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.71e-05	0.000639	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	7.67e-05	0.000636	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	7.56e-05	0.000627	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.5e-05	0.000622	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.03e-05	0.000583	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BLVRB—esophageal cancer	6.85e-05	0.000568	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC52A3—esophageal cancer	6.85e-05	0.000568	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.8e-05	0.000564	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.73e-05	0.000558	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	6.7e-05	0.000556	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BLVRB—esophageal cancer	6.69e-05	0.000555	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC52A3—esophageal cancer	6.69e-05	0.000555	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—EP300—esophageal cancer	6.59e-05	0.000547	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BLVRB—esophageal cancer	6.25e-05	0.000518	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC52A3—esophageal cancer	6.25e-05	0.000518	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.12e-05	0.000508	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	5.82e-05	0.000483	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA1—esophageal cancer	5.82e-05	0.000483	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.77e-05	0.000479	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA1—esophageal cancer	5.68e-05	0.000471	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC10A2—esophageal cancer	5.68e-05	0.000471	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.61e-05	0.000465	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.58e-05	0.000463	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	5.48e-05	0.000455	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA2—esophageal cancer	5.33e-05	0.000442	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA1—esophageal cancer	5.31e-05	0.00044	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	5.31e-05	0.00044	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.21e-05	0.000432	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA2—esophageal cancer	5.2e-05	0.000431	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.96e-05	0.000411	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLCE1—esophageal cancer	4.95e-05	0.000411	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADH7—esophageal cancer	4.95e-05	0.000411	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.9e-05	0.000406	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CA—esophageal cancer	4.88e-05	0.000404	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA2—esophageal cancer	4.86e-05	0.000403	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADH7—esophageal cancer	4.83e-05	0.000401	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLCE1—esophageal cancer	4.83e-05	0.000401	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.79e-05	0.000398	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.75e-05	0.000394	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.56e-05	0.000378	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCE1—esophageal cancer	4.52e-05	0.000375	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADH7—esophageal cancer	4.52e-05	0.000375	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.46e-05	0.00037	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADH1B—esophageal cancer	4.34e-05	0.00036	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADH1B—esophageal cancer	4.24e-05	0.000352	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TYMP—esophageal cancer	4.15e-05	0.000344	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.15e-05	0.000344	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.12e-05	0.000342	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.12e-05	0.000342	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TYMP—esophageal cancer	4.05e-05	0.000336	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	4.04e-05	0.000335	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.98e-05	0.00033	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADH1B—esophageal cancer	3.96e-05	0.000328	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.94e-05	0.000327	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALOX15—esophageal cancer	3.93e-05	0.000326	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.89e-05	0.000322	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALOX15—esophageal cancer	3.84e-05	0.000318	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TYMP—esophageal cancer	3.78e-05	0.000314	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TPI1—esophageal cancer	3.75e-05	0.000311	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.75e-05	0.000311	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	3.68e-05	0.000305	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTO1—esophageal cancer	3.66e-05	0.000304	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TPI1—esophageal cancer	3.66e-05	0.000304	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDOB—esophageal cancer	3.6e-05	0.000298	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALOX15—esophageal cancer	3.59e-05	0.000298	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDOB—esophageal cancer	3.51e-05	0.000291	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.5e-05	0.00029	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA1—esophageal cancer	3.5e-05	0.00029	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GAPDH—esophageal cancer	3.46e-05	0.000287	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CRABP1—esophageal cancer	3.43e-05	0.000285	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TPI1—esophageal cancer	3.42e-05	0.000284	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTO1—esophageal cancer	3.42e-05	0.000284	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GAPDH—esophageal cancer	3.38e-05	0.00028	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.37e-05	0.00028	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CRABP1—esophageal cancer	3.35e-05	0.000278	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDOB—esophageal cancer	3.28e-05	0.000272	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GNG7—esophageal cancer	3.27e-05	0.000271	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.26e-05	0.000271	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA2—esophageal cancer	3.2e-05	0.000266	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GNG7—esophageal cancer	3.19e-05	0.000264	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GAPDH—esophageal cancer	3.16e-05	0.000262	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CRABP1—esophageal cancer	3.13e-05	0.00026	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDH2—esophageal cancer	3.06e-05	0.000254	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDH2—esophageal cancer	2.99e-05	0.000248	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.98e-05	0.000247	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADH7—esophageal cancer	2.98e-05	0.000247	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GNG7—esophageal cancer	2.98e-05	0.000247	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.91e-05	0.000241	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.88e-05	0.000239	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.87e-05	0.000238	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—esophageal cancer	2.84e-05	0.000236	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.81e-05	0.000233	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.79e-05	0.000231	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO1—esophageal cancer	2.73e-05	0.000226	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.73e-05	0.000226	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PSME2—esophageal cancer	2.69e-05	0.000223	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PSME1—esophageal cancer	2.69e-05	0.000223	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS1—esophageal cancer	2.66e-05	0.000221	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO1—esophageal cancer	2.66e-05	0.000221	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.66e-05	0.000221	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.65e-05	0.00022	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.62e-05	0.000218	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PSME1—esophageal cancer	2.62e-05	0.000218	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PSME2—esophageal cancer	2.62e-05	0.000218	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.61e-05	0.000217	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.61e-05	0.000217	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TYMP—esophageal cancer	2.5e-05	0.000207	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO1—esophageal cancer	2.49e-05	0.000206	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.49e-05	0.000206	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PSME1—esophageal cancer	2.45e-05	0.000203	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PSME2—esophageal cancer	2.45e-05	0.000203	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.43e-05	0.000201	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.37e-05	0.000196	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.35e-05	0.000195	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.32e-05	0.000192	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.26e-05	0.000188	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.26e-05	0.000187	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.26e-05	0.000187	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.18e-05	0.000181	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.16e-05	0.000179	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.14e-05	0.000177	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.13e-05	0.000176	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.11e-05	0.000175	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.08e-05	0.000173	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.06e-05	0.000171	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.99e-05	0.000165	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.99e-05	0.000165	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.96e-05	0.000163	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.95e-05	0.000162	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.94e-05	0.000161	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.91e-05	0.000158	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.84e-05	0.000153	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.81e-05	0.00015	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.78e-05	0.000148	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.75e-05	0.000145	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.74e-05	0.000144	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.73e-05	0.000143	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.64e-05	0.000136	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.64e-05	0.000136	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.62e-05	0.000134	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.62e-05	0.000134	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.44e-05	0.00012	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.39e-05	0.000116	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.32e-05	0.000109	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.31e-05	0.000109	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.28e-05	0.000106	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.25e-05	0.000103	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.2e-05	9.92e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.16e-05	9.65e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.15e-05	9.52e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—esophageal cancer	1.14e-05	9.48e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—esophageal cancer	1.12e-05	9.25e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.05e-05	8.67e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—esophageal cancer	1.04e-05	8.64e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.02e-05	8.46e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—esophageal cancer	9.53e-06	7.9e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—EP300—esophageal cancer	8.69e-06	7.21e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—EP300—esophageal cancer	8.48e-06	7.04e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—EP300—esophageal cancer	7.92e-06	6.57e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CREBBP—esophageal cancer	7.67e-06	6.36e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—esophageal cancer	6.87e-06	5.7e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	6.43e-06	5.33e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.28e-06	5.21e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.28e-06	5.2e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	5.86e-06	4.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—EP300—esophageal cancer	5.23e-06	4.33e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.87e-06	3.21e-05	CbGpPWpGaD
